GGrantIndex
Sort

172,184 grants matching inflammation

AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS

$749,986
Avraham Beigelman · Washington University · R01 · FY2017 · HL

Refinement of lead compounds to modulate water permeability through AQP4

$749,969
Marc F Pelletier · Aeromics, Inc · R44 · FY2011 · NS

The Impact of Oral Health on Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy (OHART)

$749,957
Temitope T Omolehinwa · University Of Pennsylvania · R01 · FY2021 · DE

Phase II Clinical Trial of Lactoferrin in Asthma

$749,920
Agennix, Inc. · R44 · FY2005 · AI

Assessing SARS-CoV-2 Variant Evolution in Patients

$749,891
Richard G Wunderink · Northwestern University At Chicago · U19 · FY2021 · AI

EVALUATION OF NOVEL POLYUNSATURATED FATTY ACID DERIVED LIPID MEDIATORS OF INFLAMMATION TO AMELIORATE THE DELETERIOUS EFFECTS OF BLAST OVER PRESSURE ON EYE AND BRAIN VISUAL PROCESSING CENTERS IN RATS

$749,870
The Geneva Foundation · · FY2012 · Department of the Army

The microbiome and aging in Clostridioides difficile infection

$749,862
Vincent B Young · University Of Michigan At Ann Arbor · R01 · FY2024 · AI

Hyperglycemia and Pregnancy Outcome(HAPO) Follow Up Study

$749,861
Boyd E Metzger · Northwestern University At Chicago · U01 · FY2016 · DK

Multiphoton intravital microscope

$749,854
Margarida Barroso · Albany Medical College · S10 · FY2024 · OD

Functional Analysis of Complement Variants in a Genotyped iPSC Epithelial Cell Model System

$749,831
Dwight E Stambolian · University Of Pennsylvania · R01 · FY2025 · AI

Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus

$749,831
Matthew James Magee · Emory University · R01 · FY2025 · AI

Pulmonary Hypertension in Genetically Modified Mice

$749,819
Marlene Rabinovitch · Stanford University · R01 · FY2021 · HL

Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure

$749,786
Arjun Deb · University Of California Los Angeles · R01 · FY2023 · HL

CANCER AND INFLAMMATION: FUNCTION AND THERAPY

$749,761
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

CANCER AND INFLAMMATION GENETICS

$749,761
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2

$749,747
Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2025 · AI

Novel SIV Model of HAND

$749,734
Janice Ellen Clements · Johns Hopkins University · R01 · FY2014 · NS

Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease

$749,725
Philip Bauer · Endoprotech, Inc. · R44 · FY2016 · AA

Mechanistic Studies of NAD+/NADH in Human Heart Failure

$749,718
Kevin D. O'Brien · University Of Washington · R01 · FY2023 · HL

A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction

$749,712
Philip Bauer · Endoprotech, Inc. · R44 · FY2018 · HL

EFFECT OF ALM DRUG THERAPY TO REDUCE INFLAMMATION AND SCAR FORMATION AFTER ACL RECONSTRUCTION SURGERY: TARGETING EARLIER RETURN TO ACTIVE DUTY

$749,659
James Cook University · · FY2020 · Defense Health Agency

Immunopathogenesis of HIV-associated pulmonary hypertension

$749,651
Karen A Norris · University Of Georgia · R01 · FY2016 · HL

Housing, Environment, And Living Conditions for Transformed Health (HEALTHe Birmingham)

$749,634
Gabriela R Oates · University Of Alabama At Birmingham · U01 · FY2024 · NR

Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain

$749,597
Schahram Akbarian · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA

The Lung DNA Virome in Health and Disease

$749,556
Ronald G Collman · University Of Pennsylvania · R33 · FY2020 · HL